Dosage regimen

Intranasally.

Snoop® nasal spray 0.05%

Children aged 2 to 6 years, 1 injection in each nostril (if necessary, you can repeat it), up to 3 times / day.

Adults and children from 6 years old, 2 injections into each nostril, up to 3 times / day.

Snoop® nasal spray 0.1%

Adults and children from 6 years old, 1 injection into each nostril (if necessary, you can repeat it), up to 3 times / day.

Snoop® nasal spray 0.1% should not be used in children under 6 years of age.

The drug should not be used more than 3 times / day, the duration of the course is no more than 7 days.

Before use, you must clean the nasal passages. Remove the protective cap. Before the first use, press the rim of the spray nozzle several times until an even cloud of "mist" appears. The bottle with the drug is ready for further use.

When using the nozzle, insert it into the nasal cavity and press the rim once. Keep the bottle upright. Do not spray horizontally or downward. It is recommended to inhale slightly through the nose immediately after the injection. After use, close the bottle with a protective cap.

Each bottle should be used individually.

After completion of therapy, the drug can be re-prescribed only after a few days. The duration of use in children should be consulted with a doctor. In the case of chronic rhinitis, Snoop® 0.05% and 0.1% can be used only under medical supervision, given the risk of atrophy of the nasal mucosa. If after treatment there is no improvement or symptoms worsen, or new symptoms appear, you should consult your doctor. The drug should be used only according to the indications, the method of use and in those doses indicated in the instructions.

Hypersensitivity to xylometazoline and any other component of the drug;

arterial hypertension;

tachycardia;

severe atherosclerosis;

increased intraocular pressure, especially angle-closure glaucoma;

atrophic rhinitis;

hyperthyroidism;

surgical interventions on the meninges (in history);

inflammatory diseases of the skin or mucous membrane of the vestibule of the nose;

conditions after transsphenoidal hypophysectomy;

pregnancy;

children under 6 years of age (for 0.1% solution);

children under 2 years of age (for a 0.05% solution).

Do not use during therapy with MAO inhibitors (including 14 days after their cancellation), tricyclic and tetracyclic antidepressants, other local vasoconstrictor drugs (decongestants), as well as other drugs that increase blood pressure.

Carefully

Diabetes mellitus, severe cardiovascular diseases (including coronary artery disease, angina pectoris), prostatic hyperplasia, pheochromocytoma, porphyria, breastfeeding, hypersensitivity to adrenergic drugs, accompanied by insomnia, dizziness, arrhythmia, tremor, increased blood pressure.

Application during pregnancy and lactation

During pregnancy, the use of the drug is contraindicated.

During the period of breastfeeding, the drug should be used only after a thorough assessment of the risk-benefit ratio for the mother and the infant, it is not allowed to exceed the recommended dosage. During breastfeeding, you should consult your doctor before using Snoop®.

Application in children

Contraindication: children under 6 years of age (for 0.1% solution). In children under 2 years of age, only a 0.05% solution of the drug should be used.

Do not exceed recommended doses in children.

Use in elderly patients

The recommended dose should not be exceeded in elderly patients.

Determination of the frequency of occurrence of adverse reactions: very often (> 1/10); often (> 1/100 to <1/10), infrequently (> 1/1000 to <1/100), rarely (> 1/10 000 to <1/1000); very rare (<1/10 000).

From the immune system: very rarely - hypersensitivity reactions (angioedema, rash, itching).

From the nervous system: often - headache; rarely - insomnia, depression (with prolonged use in high doses); very rarely - anxiety, fatigue, paresthesia, hallucinations and convulsions (mainly in children).

From the senses: very rarely - a violation of the clarity of visual perception.

From the side of the cardiovascular system: rarely - a feeling of palpitations, increased blood pressure; very rarely - tachycardia, arrhythmia.

From the respiratory system: often - irritation and / or dryness of the nasal mucosa, burning, tingling, sneezing, hypersecretion of the nasopharyngeal mucosa; rarely - after using the drug, there may be an increase in swelling of the nasal mucosa (reactive hyperemia), bleeding from the nose.

From the digestive system: often - nausea; rarely - vomiting.

Local reactions: often - burning at the site of application.

If the patient develops or aggravates the above side effects, or any other side effects are noted, he should inform the doctor about it.

The simultaneous use of xylometazoline with MAO inhibitors, tricyclic and tetracyclic antidepressants, other local vasoconstrictor agents (decongestants), as well as other drugs that increase blood pressure, can lead to an increase in blood pressure, therefore, the simultaneous use of these drugs is contraindicated. If the patient uses the above or other drugs (including over-the-counter), consult a doctor before using Snoop®.

Symptoms: in case of an overdose of the drug, the clinical picture is an alternation of phases of CNS excitation (anxiety, agitation, hallucinations, convulsions) with phases of CNS depression (decrease in body temperature, lethargy, drowsiness, coma). The following symptoms may also occur: miosis, mydriasis, increased sweating, fever, pallor, cyanosis, nausea and vomiting, tachycardia, bradycardia, cardiac arrhythmias, cardiac arrest, palpitations, increased blood pressure, lowering blood pressure up to shock, pulmonary edema, depression breathing and apnea, psychogenic disorders.

In children with overdose, dominant central effects are observed with convulsions, coma and bradycardia, apnea, as well as an increase in blood pressure, followed by arterial hypotension.

Treatment: symptomatic, under medical supervision.

In case of accidental ingestion of the drug inside - the introduction of activated carbon, gastric lavage.

In case of severe overdose, intensive care is indicated in a hospital. In severe cases, non-selective alpha-blockers can be used to lower blood pressure, antipyretics, intubation, and mechanical ventilation.